- Home
- MTCH vs STVN Comparison
MTCH vs STVN Comparison
Compare MTCH & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTCH
- STVN
- Stock Information
- Founded
- MTCH 1986
- STVN 1949
- Country
- MTCH United States
- STVN Italy
- Employees
- MTCH N/A
- STVN N/A
- Industry
- MTCH Computer Software: Programming Data Processing
- STVN Containers/Packaging
- Sector
- MTCH Technology
- STVN Consumer Discretionary
- Exchange
- MTCH Nasdaq
- STVN Nasdaq
- Market Cap
- MTCH 7.2B
- STVN 6.6B
- IPO Year
- MTCH 2015
- STVN 2021
- Fundamental
- Price
- MTCH $29.96
- STVN $22.14
- Analyst Decision
- MTCH Buy
- STVN Buy
- Analyst Count
- MTCH 19
- STVN 6
- Target Price
- MTCH $35.89
- STVN $25.08
- AVG Volume (30 Days)
- MTCH 5.5M
- STVN 326.1K
- Earning Date
- MTCH 05-08-2025
- STVN 05-08-2025
- Dividend Yield
- MTCH 1.27%
- STVN 0.27%
- EPS Growth
- MTCH N/A
- STVN N/A
- EPS
- MTCH 2.03
- STVN 0.50
- Revenue
- MTCH $3,450,904,000.00
- STVN $1,215,562,040.00
- Revenue This Year
- MTCH $1.20
- STVN $8.42
- Revenue Next Year
- MTCH $4.15
- STVN $10.44
- P/E Ratio
- MTCH $14.77
- STVN $44.76
- Revenue Growth
- MTCH 0.40
- STVN 3.81
- 52 Week Low
- MTCH $26.39
- STVN $16.56
- 52 Week High
- MTCH $38.84
- STVN $25.75
- Technical
- Relative Strength Index (RSI)
- MTCH 49.69
- STVN 46.39
- Support Level
- MTCH $28.99
- STVN $21.97
- Resistance Level
- MTCH $30.95
- STVN $24.43
- Average True Range (ATR)
- MTCH 0.78
- STVN 1.28
- MACD
- MTCH 0.13
- STVN -0.21
- Stochastic Oscillator
- MTCH 58.26
- STVN 7.67
About MTCH Match Group Inc.
Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. The company generates the majority of its revenue from the Tinder segment.
About STVN Stevanato Group S.p.A.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.